Copyright
©The Author(s) 2015.
World J Nephrol. May 6, 2015; 4(2): 185-195
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.185
Published online May 6, 2015. doi: 10.5527/wjn.v4.i2.185
Disease | Molecular defect | Prevalence | Main glomerular defect | Clinical expression | ||
Haematuria | Proteinuria | CKD progression | ||||
Genetic disorder | ||||||
GFB structural damage | ||||||
Structural GBM damage | ||||||
ALPORT | X-linked: COL4A5 AR: COL4A3/COL4A4 | 1/50000 | GBM | MH | Variable | 100% approximately 20-30 yr |
TBMD | COL4A3/COL4A4 | 1% | GBM | MH | Usually absent | 20% CKD |
HANAC | COL4A1 | 3 families | GBM | MH or gross | Not described | Variable |
Structural podocyte damage | ||||||
MYH9 | Non muscle myosin IIA heavy chain | 1:100000 | None | MH | Variable | ESRD by young adulthood |
Storage disorders | ||||||
Fibronectine GN | Fibronectin | 44 cases | Mesangial/subendoth | 60% MH | 93% variable degree | ESRD at 20-60 yr |
Fibrillary | 10-30 nm fibrils | Rare | Mesangial /GBM | MH 47%-73% Gross 5% | Present 41%-55% nephrotic | 50% ESRD in few years |
Immunotactoid | > 30 nm fibrils | 10-fold rarer than FGN | Mesangial/subepith/subendoth | MH 80% | 100% | 17% ESRD in 3 yr |
Fabry’s disease | Lysosomal storage | 1:3100- 1:1600 | All the cells | MH | Usually nephrotic | ESRD after age 50 yr |
Complement mediated | ||||||
C3 glomerulopathy | Alternative pathway | 1-2 × 106 | Mesangial/GBM | MH 87% | 38% | Variable |
Inflammatory disorders | ||||||
Autoimmune | ||||||
ANCA | Ab vs endothelium | 10-20 × 106 | Endothelium | MH | Variable | Variable |
Anti GBM | Ab vs COL4 | 0.5-1 × 106/yr | GBM | MH | Variable | Variable |
Infections (endocapillary) | ||||||
Primary GN (IgAN, membranoproliferative, crescentic) | ||||||
IgAN | Galactose-deficient IgA1 | 10%-16% | Mesangial | MH always 75% gross | Rare nephrotic Usual proteinuria | 20% ESRD 20 yr after diagnosis |
Miscellaneous | ||||||
WRN | Unknown | 16.5% non-CKD 33% CKD | None | Usually MH | None | Accelerated CKD progression |
LPHS | Unknown | Unknown | GBM (?) | MH or gross | Absent or minimal | GFR > 60 |
- Citation: Yuste C, Gutierrez E, Sevillano AM, Rubio-Navarro A, Amaro-Villalobos JM, Ortiz A, Egido J, Praga M, Moreno JA. Pathogenesis of glomerular haematuria. World J Nephrol 2015; 4(2): 185-195
- URL: https://www.wjgnet.com/2220-6124/full/v4/i2/185.htm
- DOI: https://dx.doi.org/10.5527/wjn.v4.i2.185